Standout Papers

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa 2022 2026 2023 2024137
  1. Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa (2022)
    Ashlan J. Kunz Coyne, Amer El Ghali et al. Infectious Diseases and Therapy

Immediate Impact

15 standout
Sub-graph 1 of 6

Citing Papers

Nanomaterial-Based Strategies to Combat Antibiotic Resistance: Mechanisms and Applications
2025 Standout
Multidrug-resistant Gram-negative bacterial infections
2025 Standout
5 intermediate papers

Works of Nicholas Rebold being referenced

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections
2022
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections
2021
and 2 more

Author Peers

Author Last Decade Papers Cites
Nicholas Rebold 25 39 136 77 65 12 220
Dorji Harnod 26 33 131 56 47 14 238
Ali F. Aboklaish 25 73 164 39 72 13 270
Tomáš Látal 34 44 100 49 27 10 299
Ngai Kien Le 19 57 153 68 52 9 236
Zengyuan Yu 18 71 119 46 34 14 283
Jiayue Ma 19 63 129 47 36 16 262
Noemi Aiezza 62 41 184 47 71 10 242
Federica Maria Di Lella 47 56 134 53 67 13 269
Ngoc Thi Bich Hoang 13 45 150 52 46 11 214
Maxime Bour 25 38 243 52 69 19 290

All Works

Loading papers...

Rankless by CCL
2026